Axl is a receptor tyrosine kinase which promotes anti-apoptosis, mitogenesis, invasion, angiogenesis and metastasis, and is highly expressed in cancers. However, the transcriptional regulation of this important gene has never been characterized. The present study was initiated to characterize the promoter, cis-acting elements and promoter methylation driving expression of Axl. The 2.4 kb sequence upstream of the translational start site, and sequential 5 -deletions were cloned and revealed a minimal GC-rich region (−556 to +7) to be sufficient for basal Axl promoter activity in Rko, HCT116 and HeLa cells. Within this minimal region, five Sp (specificity protein)-binding sites were identified. Two sites (Sp a and Sp b) proximal to the translation start site were indispensable for Axl promoter activity, whereas mutation of three additional upstream motifs (Sp c, Sp d and Sp e) was of additional relevance. Gel-shift assays and chromatin immunoprecipitation identified that Sp1 and Sp3 bound to all five motifs, and mutation of all motifs abolished binding. Mithramycin, which inhibits binding of Sp factors to GC-rich sites, dramatically reduced Axl promoter activity and Axl, Sp1 and Sp3 expression. In Drosophila Schneider SL2-cells, exogenous expression of Sp1/Sp3 increased Axl promoter activity. Use of Sp1/Sp3 siRNAs (small interfering RNAs) significantly reduced Axl promoter activity and protein levels in Rko and HeLa cells. Methylation-bisulfite sequencing detected methylated CpG sites within three Sp motifs (Sp a, Sp b and Sp c) and GC-rich flanking sequences, and demethylation by 5-aza-2 -deoxycytidine up-regulated Axl and Sp3 expression in low-Axl-expressing Colo206f/WiDr cells, but not in high-Axl-expressing Rko cells. The results of the present study suggest that Axl gene expression in cancer cells is (1) constitutively driven by Sp1/Sp3 bound to five core promoter motifs, and (2) restricted by methylation within/around Sp-binding sites. This might enhance the understanding and treatment of essential mechanisms associated with cancer and other diseases.
INTRODUCTION
Axl (from the Greek word 'anexelekto' or uncontrolled) belongs to the Tyro 3 family of RTKs (receptor tyrosine kinases) which includes Mer and Sky, and was originally identified as a transforming gene in human leukaemias [1] . These RTKs are characterized by the presence of two immunoglobulin-like domains and two fibronectin-type III domains in the extracellular region (a
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unique extracellular structure, resembling neural cell-adhesion molecules), and a distinctive intracellular kinase domain [1] . Human Axl is a 140 kDa protein with a roughly equal distribution of amino acids on either side of the plasma membrane [1, 2] . The main ligand for Axl RTK family members is Gas6, the product of growth-arrest-specific gene 6 [3] , a soluble member of the vitamin K-dependent protein family [4] , which binds to Tyro 3 family members with different affinities. Gas6 was first discovered as a gene which is up-regulated in growth-arrested cells [5] , suggesting a role in the prevention of cellular stresses, such as apoptosis. Subsequent studies have suggested Gas6 has a role in cell survival [6, 7] , proliferation [8, 9] , stimulation of cell migration [10] and cell-cell adhesion via Axl [11] . Intracellular signalling of Axl is also activated by homophilic and heterophilic interactions [12] , mediated mainly by a multi-substrate docking site [13] . Overexpression of Axl can transform fibroblasts even in the absence of a ligand [14] . Different signalling molecules are activated by Axl in different cell types, among them being PI3K (phosphoinositide 3-kinase), Akt, Src, ERK (extracellular signal-regulated kinase) and NF-κB (nuclear factor κB) [15, 16] . Gas6/Axl signalling is well studied in NIH 3T3 mouse fibroblasts, where it is known to transduce anti-apoptotic signals via NF-κB activation and increased protein levels of Bcl-xl [17] . An increased expression of Axl is associated with invasion, metastasis and angiogenesis in various cancer cells, and is found in metastatic colon and prostate carcinoma, gastric, endometrial and certain types of breast cancers, and in sarcomas [18] .
The Axl gene is located on human chromosome 19, encoded by 20 exons, and distributed over a region of 44 kb. Different isoforms of Axl mRNA are generated by alternative splicing of exon 10 [19] . Until now, no functional differences have been found for these isoforms. In one initial study, the Axl 5 -upstream region was shown to be GC-rich, lack TATA and CAAT boxes, and harbour multiple transcription start sites. These transcription start sites include the major start site at −169, and a second major start site at −460, upstream of the translation start site [19] . However, although Axl has been shown to influence different major cell physiological properties and to be associated with diverse cancers and cancer-specific properties, surprisingly little is known about its transcriptional regulation, and no further studies on the characterization of its promoter have been published so far.
Therefore in the present study we have characterized the Axl promoter and its methylation status in different colorectal cell lines. We identified binding sites for various transcription factors within the −556 to −182 core region upstream to the Axl translational start codon, among them five binding sites for Sp1 (specificity protein 1)/Sp3, one for MZF1 (myeloid zinc finger 1) and one for AP-1 (activator protein 1). Furthermore, we show that the Sp-binding sites, or adjacent CpG sites, are partially methylated in low-Axl-expressing cells, in contrast with high-Axl-expressing cells. The results presented here are the first to show that Sp1 and Sp3 transcription factors have an essential role in the basal expression of the Axl gene, and that the methylation status of CpG sites in, or in close proximity to, Sp-binding motifs modulates Axl gene expression in cultured colon cancer cells.
EXPERIMENTAL

Cell culture, reagents and treatments
All human cells were obtained from the A.T.C.C. (Manassas, VA, U.S. A.) , and grown at 37
• C in DMEM (Dulbecco's modified Eagle's medium), MEM (minimal essential medium), McCoy's or RPMI 1640 medium supplemented with 10% (v/v) FCS (fetal calf serum). Mock-treated control cells were handled in an identical manner with drug-treated cells, with the exception that medium only was added. Drosophila melanogaster SL-2 cells were maintained in Schneider's insect medium supplemented with 10% (v/v) FCS at 27
• C. Mithramycin was purchased from Sigma-Aldrich.
Preparation of protein extracts and immunoblotting
Cells were washed with PBS and lysed in extraction buffer (Biosource). The protein concentration was determined using the BCA (bicinchoninic acid) kit (Pierce). For immunoblotting, samples (40 μg/lane) were boiled for 5 min, separated via SDS/PAGE (10% gels), and transferred on to PVDF membranes. After transfer, the membranes were blocked with 5% (w/v) nonfat dried skimmed milk powder in TTBS (Tris-buffered saline with 0.1% Tween 20) for 3 h at room temperature (25 • C), and then probed with the indicated primary antibodies (all from Santa Cruz Biotechnology) against Sp1 (sc-59x, 1:2500 dilution) Sp3 (sc-644x, 1:5000 dilution), Axl (sc-1096, 1:1500 dilution) and β-actin (sc-1616, 1:2000 dilution) for 2 h at room temperature. After three washes with TTBS, the blots were incubated at 25
• C with either rabbit (Sp1, Sp3 and β-actin) or goat (Ax1) (1:5000 dilution) horseradish-peroxidase-conjugated secondary antibodies for 30 min. After final washes with TTBS, the membranes were exposed to film after use of ECL ® (enhanced chemiluminescence) (Amersham Biosciences).
RNA isolation and RT-PCR (reverse transcription-PCR)
Total RNA was extracted from tissue-culture cells using the RNeasy Midi kit (Qiagen) following the manufacturer's instructions. The RNA samples were quantified using a spectrophotometer and visualized on a Mops/formaldehyde gel (1% gel) for quality assurance. Total RNA (1 μg) was reverse-transcribed by random hexamer primers using SuperScript II reverse transcriptase (Invitrogen). The single strand cDNA was amplified by PCR using specific primer pairs. GAPDH (glyceraldehyde-3-phosphate dehydrogenase) was used as an internal control. The PCR products were analysed by electrophoresis on a 2% (w/v) agarose gel stained with ethidium bromide. The sequences of the sense and antisense primers used for RT-PCR were: GAPDH (sense, 5 -GTCTTCACCACCATGGAGAA-3 and antisense, 5 -ATCCACAGTCTTCTGGGTGG-3 ) and Axl (sense, 5 -GGTGGCTGTGAAGACGATGA-3 and antisense, 5 -CTCAGATACTCCATGCCACT-3 ). , anti-Sp2 (sc-643x), anti-Sp3 (sc644x), anti-Sp4 (sc-645x) and rabbit anti-IgG (sc-2338x) antibodies (all purchased from Santa Cruz Biotechnology)] was added to the reactions 20 min after the nuclear extracts and oligonucleotide had been incubated. Supershift reactions were incubated for 60 min at 4
• C and electrophoresed at 4
• C to ensure complex stability. The gels were dried and analysed by autoradiography. As a negative control, a lane without nuclear extract and oligonucleotides was processed in each EMSA.
Generation of luciferase reporter constructs
Approx. 2400 bp of the upstream sequence from the translation start of the Axl gene was amplified by PCR from human genomic DNA and cloned into the pGL3-Basic vector (Promega) using KpnI and XhoI restriction sites. A series of different truncated fragments of the Axl promoter were created by PCR amplification from this 2.4 kb fragment with the primers listed in Table 2 and inserted into pGL3-Basic using the same restriction sites.
Expression vectors
Expression vectors containing human Sp1/Sp3 (pCMV-Sp) and Drosophila Sp1/Sp3 (pPac-Sp) transcription factors were gifts from Dr Guntram Suske [Institut für Molekularbiologie und 
Site-directed mutagenesis analysis
Mutant constructs were generated using the QuikChange ® XL site-directed mutagenesis kit (Stratagene) using AxlP3 (−1276 to +7) as the DNA template. The sequences of the mutant oligonucleotides used are detailed in Table 1 . Successful incorporation of the mutations was confirmed by automated DNA sequencing.
Transfection and luciferase assays in mammalian cell lines
For luciferase assays, 1. . For all luciferase reporter assays, pRL-TK (50 ng, Renilla luciferase; Promega) was also co-transfected and measured to normalize transfection efficiency. After 6 h of transfection, optimum medium was replaced with regular medium, and the cells were incubated at 37
• C for 48 h. Cells were washed twice with PBS and lysed with 100 μl of passive lysis buffer (Promega) for 20 min. Luciferase activity (20 μl of cell lysate) was measured via the Dual-Luciferase reporter assay system (Promega) following the manufacturer's instructions. Assays for all samples were performed in triplicate, and the means of the results were calculated.
Luciferase assays in Drosophila melanogaster SL2 insect cells
For luciferase assays, at the time of transfection 5 × 10 5 cells were plated into a 24-well plate. AxlP3 (250 ng) was co-transfected with 150 ng of either Sp1 or Sp3 along with Renilla luciferase as an internal control for transfection efficiency, using Effectene transfection reagent (Qiagen). After 48 h of transfection, cells were collected in Eppendorf tubes and lysed with 100 μl of passive lysis buffer (Promega). Luciferase activity (50 μl of cell lysate) was measured via the Dual-Luciferase reporter assay system (Promega) following the manufacturer's instructions. Assays for all samples were performed in triplicate, and the means of the results were calculated.
ChIP (chromatin immunoprecipitation) assay
ChIP assays were performed via a commercially purchased ChIP kit (Upstate Biotechnology) using either anti-Sp1 (sc-59 X), antiSp3 (sc-644 X) or anti-IgG (as control, sc-2338 X) antibodies. Rko cells were first cross-linked by the addition of formaldehyde directly to tissue-culture medium to a final concentration of 1% and incubating for 10 min at room temperature. This was then neutralized by incubation with 125 mM glycine for 10 min. Cells were then washed twice with ice-cold PBS (with protease inhibitors), scraped, pelleted, resuspended in SDS lysis buffer [50 mM Tris/HCl (pH 8.1), 1% SDS and 10 mM EDTA] and incubated for 10 min on ice. The lysates were then sonicated ten times (15 s at 30% amplitude) and samples were rested on ice for 1 min between sonication steps. After sonication, the samples were centrifuged (18 360 g, 10 min, 4
• C), the supernatants were diluted 10-fold in ChIP dilution buffer [16. 7 mM Tris/HCl (pH 8.1), 0.01% SDS, 1.1% (v/v) Triton X-100, 1.2 mM EDTA and 167 mM NaCl] with protease inhibitors, and pre-cleared with 80 μl of salmon sperm DNA/protein A-agarose for 30 min at 4
• C. Cross-linked chromatin was incubated overnight at 4
• C with 3 μg of anti-Sp1, 3 μg of anti-Sp3 or 3 μg of control anti-IgG antibodies in a total volume of 1 ml. Antibody-protein-DNA complexes were isolated by immunoprecipitation with 60 μl of salmon sperm DNA/protein A. After extensive washing, pellets were eluted by freshly prepared elution buffer (1% SDS and 0.1 M NaHCO 3 ). Formaldehyde crosslinking was reversed by 6 h incubation at 65
• C. Samples were purified through PCR purification kit columns (Qiagen) and used as templates for PCR. The primers used for ChIP were as follows: region 1, sense 5 -CCTGGCCCCTTTAAGAAAG-3 and antisense 5 -CTGCCTCCTTCCCTCACT-3 ; and region 2, sense 5 -GTGTGTGTGTGTCCTTGTCC-3 and antisense 5 GGGCTCTGTGTCTGGTAAAC 3 . These were used to amplify a 159 bp and 168 bp fragment corresponding to the core Axl promoter. As a negative control, a region in the uPAR (urokinase plasminogen activator receptor) promoter region (from −937 to −745) was amplified with the following primers (sense 5 -GCAGACATCAATAACATTCACC-3 and antisense 5 -GCCTGGCAACAGAACAAGAC-3 ). Amplification of soluble chromatin prior to immunoprecipitation was used as an input control. 
Knockdown of Sp1 or
5-aza-dC (5-aza-2 -deoxycytidine) treatment
Cells were plated in a six-well plate in their respective medium supplemented with 10% (v/v) FCS, and allowed to grow for 24 h. Cells were treated either with a final concentration of 10, 20 or 40 μM 5-aza-dC for 5 days, changing the drug every 24 h, or with 10% (v/v) FCS-supplemented medium as a control. On the fifth day, cells were washed with PBS and grown without treatment for 24 h. Finally, cells were washed with ice-cold PBS and total RNA was isolated using the Qiagen RNeasy mini kit.
Sodium bisulfite conversion of DNA
WiDr or Rko genomic DNA (1 μg) was used for bisulfite conversion using the EpiTect Bisulfite Kit (Qiagen) following the manufacturer's instructions. Bisulfite-treated DNA was amplified with two sets of methylation-specific primers. Axl 5 -flanking region-specific primers were: set one (amplified product −376 to −98) sense 5 -GGGTATAGTTATTAGGGTTTTTTTT-3 and antisense 5 -TTTAACACTACCTACCTAACACAAC-3 , and set two (amplified product −669 to −357) sense 5 -TGTTTTAGT-TTGTGTGTGTTAGTGA-3 and antisense 5 -AAACCCTAA-TAACTATACCCCCTATC-3 . PCR was performed as follows: 94
• C for 2 min, 30 cycles of 94
• C for 30 s, annealing at 62
• C for 30 s and extension at 72
• C for 45 s, and final extension at 72
• C for 5 min. Purified PCR products were used for pGMT-easy cloning and ten clones were examined by DNA sequencing from each cell line.
Statistical analysis
Statistical analyses were performed using SPSS statistical software (SPSS, Chicago, IL, U.S. A.) . Differences between groups were calculated with the Student's t test, and P values of 0.05 were considered to be statistically significant. 
RESULTS
Cloning and putative regulatory elements of the Axl 5 -flanking region
To define the Axl promoter and identify potential cis-elements involved in the transcriptional regulation of Axl, we isolated the 5 -flanking region of 2376 bp upstream of the translation start site. The sequence does not contain typical TATA and CAAT boxes or an initiator sequence (see Supplementary Figure S1a at http://www.bioscirep.org/bsr/028/bsr0280161add.htm). As published previously, the promoter has different transcriptional start sites, including two major sites located at −169 and −460 upstream of the translation start site [19] . A TRANSFAC database search (GenBank ® accession number BC032229) revealed several putative-binding sites for transcription factors including MZF1 and AP-1, and multiple Sp-binding sites. On the basis of potential cis-elements and major transcriptional start sites, we generated a series of 5 -promoter deletion constructs as outlined in Figure 1 (a). Rko, HCT116 and HeLa cell lines, characterized by high-basal mRNA levels of Axl ( Supplementary Figure S1b), were used for the present study. In the rest of the present study, we will concentrate on characterizing the minimally required core promoter for constitutive expression of the Axl gene.
Functional delineation of the basal Axl promoter region
To determine the minimal Axl promoter region and narrow down the cis-elements regulating basal Axl gene expression, we transfected a series of deletion luciferase constructs (Figure 1a) into Rko, HCT116 and HeLa cells. The AxlP3 construct (−1276 to +7) exhibited a maximum percentage of luciferase activity compared with the promoterless luciferase vector pGL3-basic (Figure 1b) . Further deletion constructs, AxlP4 (−1010 to +7), AxlP5 (−727 to +7), AxlP6 (−614 to +7), AxlP7 (−556 to +7) and AxlP8 (−478 to +7), showed a gradual decrease in luciferase activity in Rko, HCT116 and HeLa cells, with the activity of the last two constructs being comparable (Figure 1b) . AxlP1 (−2376 to +7) and AxlP2 (−1759 to +7) contain more of the 5 flanking promoter region than AxlP3; however, these constructs do not show more promoter activity than AxlP3, indicating that the maximum promoter activity lies within −1272 to +7. AxlD1 (−2376 to −338), which lacks the major transcriptional start site, showed similar luciferase activity when compared with AxlP1, suggesting that both of the major transcription start sites are important. Correspondingly, AxlD2 (−556 to −338), which also contains the second major transcription start site, showed similar luciferase activity to AxlP7 (−556 to +7), which contains both major transcription start sites. AxlP9 (−181 to +7) and AxlD3 (−478 to −338) do not contain any GC-rich regions and show a complete loss of luciferase activity, comparable with pGL3-Basic control vector activity ( Figure 1b) . Taken together, although maximum promoter activity lies within −1272 to +7, our results suggest that the 5 -flanking region of Axl located between −556 to −182 includes the minimally required core promoter, since activity of AxlP7 (−556 to +7) and AxlP8 (−478 to +7) are similar, and luciferase activity is completely absent downstream of −478. The region −556 to −182 of the promoter is GC-rich, and in a TRANSFAC database search is predicted to bind zinc-finger proteins, such as Sp family transcription factors (Figure 1c ), but also AP-1 and MZF1. Overall, our observations with all of the deletion constructs were similar in the Rko, HCT116 and HeLa cell lines, excluding cell-line specific biases. Table 1 ). Mutant and wild-type constructs were transfected into Rko and HeLa cell lines and compared for reporter activity. We observed that all single mutants and combination mutants significantly reduced promoter activity compared with the wild-type construct in both cell lines, with the exception of Sp c activity in Rko cells (Figure 2b) . The single mutant constructs Sp a, Sp b, Sp d and Sp e showed 40%, 60%, 30% and 30% reduced activity respectively compared with wild-type in Rko cells, and 40%, 30%, 60% and 60% reduced activity respectively in HeLa cells. Out of the combined mutant constructs, Sp ab (Sp a and Sp b both mutated) and Sp abcde (all five motifs mutated) showed the most dramatic (70%) reduction in promoter activity in both of the cell lines examined. Even though all motifs were mutated in Sp abcde, it did not reduce promoter activity further when compared with the Sp ab mutant construct. However, the Sp cde combination mutant construct alone reduced reporter activity by 50% in both of the cell lines, implying the existence of a co-operative function of these Sp motifs. In addition to Sp mutations, other mutant constructs were generated based on MZF1 and AP-1 consensusbinding domains at −564 to −556 and −297 to −292, yet neither of these affected basal promoter activity (results not shown). Taken together, the results suggests that all Sp-binding sites are relevant for Axl core promoter activity, with Sp a and Sp b being essential.
Nuclear proteins of the Sp family bind different motifs of the Axl core promoter
To demonstrate the binding of Sp family member transcription factors to their respective binding sites in the core promoter of Axl, EMSAs were performed using Rko cell nuclear extracts, and radiolabelled wild-type and mutant probes (Table 1) . Sp c, Sp d and Sp e are in close proximity to each other; therefore, a competition experiment was conducted with increasing concentrations of 25× and 50× of either individual mutant (Sp c, Sp d or Sp e) or combination mutant (Sp cde) oligonucleotides (using the oligonucleotides synthesized for site-directed mutagenesis), with the Sp d wild-type oligonucleotide being used for labelling, and 50× unlabelled oligonucleotide for non-radioactive competition ( Figure 3a) . As shown in Figure 3 (a), competition with mutant Sp c and Sp d completely or partially abolished binding of Sp transcription-factor complexes, suggesting that the binding of some of the factors stayed intact, whereas when mutant Sp e was used as a competitor, most of the Sp transcription-factors complexes stayed intact. Competition with an oligonucleotide mutated for Sp cde did not change the binding complexes, even when used at increasing concentrations. These results show that transcription factors are binding to this region; however, they are binding predominately to the Sp e site. The same kind of competition experiment was performed for the Sp a and Sp b sites with their respective labelled wild-type oligonucleotides. We observed intact binding complexes even after the addition of increasing concentrations of Sp a and Sp b mutant oligonucleotides (Figure 3a) . The wild-type competition specifically abolished binding to Sp a and Sp b, suggesting sequence-specific binding of nuclear proteins. To confirm that the specific complexes bound in the EMSA are indeed composed of Sp family members, we performed supershift assays for the Sp a, Sp b and Sp cde motifs using antibodies against Sp1, Sp2, Sp3, Sp4, and IgG as a control (Figure 3b) . For all three motifs, the incubation with Sp1, Sp2 and Sp3 antibodies led to a shift of the major bands, implicating the presence of these Sp family members. Individual supershift analysis of Sp c and Sp e also showed binding of Sp1 and Sp3 (results not shown).
In order to analyse the binding of Sp family members to the endogenous Axl promoter, we used functionally well-characterized antibodies against Sp1 or Sp3 in ChIP analysis in Rko cells. 
Mithramycin represses Axl promoter activity and decreases Axl mRNA and protein levels
To further assess the functional relevance of Sp transcription factors on Axl gene expression, cells were treated with mithramycin, which binds to GC-rich DNA sequences and impedes the binding of GC-specific transcription factors by steric hindrance [21] . These observations confirm that the GC-rich and Sp-binding sequences identified contain Axl core promoter activity and this is effectively blocked by mithramycin.
To investigate the mithramycin effect on Axl gene expression, Rko cells were treated with 100 nM mithramycin for 4, 8, 16 or 24 h and compared with a control treated with medium only for 24 h. We found that treatment of Rko cells with mithramycin led to an almost 90% decrease in expression of Axl mRNA and protein after 16 h (Figures 4c and 4d) . Since Sp1 and Sp3 genes also contain GC-rich promoters driven by Sp family members, we additionally screened Sp1 and Sp3 mRNA and protein levels following mithramycin treatment. Sp1 and Sp3 mRNA levels were decreased 4 h after treatment, and completely undetectable 16 h after treatment, which was paralleled by a decrease in Sp1/Sp3 protein amounts (Figures 4c and 4d) . These results suggests that mithramycin not only inhibits the binding of Sp1 and 
Sp1 or Sp3 increase Axl promoter activity and gene expression
Next, the effect of Sp1 and Sp3 overexpression on the activity of the Axl promoter in Rko cells was investigated. Rko cells were co-transfected with the AxlP3 (−1276 to +7) construct, or the mutant constructs for Sp a, Sp b, Sp cde and Sp abcde respectively, and increasing concentrations of either Sp1 or Sp3 expression vectors. Overexpression of Sp1 and Sp3 led to a significant increase in Axl wild-type promoter activity in a dose-dependent manner (Figure 5a ). In contrast, the mutant constructs Sp a, Sp b, Sp cde and Sp abcde showed a significant reduction in responsiveness to Sp1 or Sp3. Specifically, mutant Sp a and Sp b did not show any response to Sp3 overexpression compared with their vector controls, and the Sp cde mutant showed a 50% reduction in response to Sp3 compared with AxlP3 wild-type. The Sp1 response was reduced by 80%, 100% and 50% for mutant Sp a, Sp b and Sp cde respectively compared with AxlP3 wild-type (Figure 5b) . The Sp abcde mutant did not show a significant response to Sp1 or Sp3 overexpression (Figure 5b) . The activity of the Sp abcde mutant following Sp1 or Sp3 overexpression was dramatically reduced compared with AxlP3 wild-type (Figure 5b) . These results confirmed that Sp a and Sp b are mediating Axl promoter activity following Sp1/Sp3 overexpression, with an additional role for the Sp cde site.
The Axl promoter is especially regulated by Sp1 or Sp3, both of which are often expressed ubiquitously in mammalian cells [21] . To gain further evidence for Sp1 or Sp3 being essential for promoter activity, the Drosophila SL2 cell line, which is devoid of endogenous human Sp family members, was co-transfected with AxlP3 and either PacSp1 or PacSp3 (insect-expression vectors encoding human Sp1 or Sp3 respectively). Both Sp1 and Sp3 strongly induced AxlP3 promoter activity (150% activity),   . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
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C suggesting that either of these transcription factors alone can positively drive Axl gene expression (Figure 5d) .
To gain evidence that Sp1 and Sp3-driven Axl gene expression is relevant at the protein level, Rko cells were transfected with 4 μg of Sp1, Sp3 or a control (mock, vector only). Both Sp1 and Sp3 increased Axl protein levels after 48 h of overexpression ( Figure 5c ) compared with the control. Taken together, it is clear that Sp1 or Sp3 positively regulate Axl gene expression.
siRNA strategies against Sp1 and Sp3 down-regulate Axl promoter activity and Axl gene expression
To provide evidence that inhibition of endogenous Sp1 or Sp3 transcription factors can inhibit Axl promoter activity and expression, siRNA knockdown experiments were performed. Either Rko or HeLa cells were transfected with either Sp1 or Sp3-specific siRNA in a dose-dependent manner. The knockdown of Sp1 and Sp3 was confirmed by Western blotting (Figures 6c and  6d) . Expression of an siRNA oligonucleotide against Sp1 or Sp3 decreased Axl promoter activity to almost 80% and 70% in Rko and to 50% and 40% in HeLa cells respectively (Figures 6a and  6b) . This was paralleled by a significant reduction in the quantity of Axl protein in the presence of increasing concentrations of siRNAs against either Sp1 or Sp3; the quantity of Axl protein being even further reduced when incubated with a combination of Sp1 and Sp3 siRNA oligonucleotides ( Figure 6 ). This confirms that the knockdown of endogenous Sp1 and Sp3 represses transactivation of the Axl promoter and basal Axl gene expression in Rko and HeLa cells.
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Axl gene expression is also dependent on DNA methylation in cultured colorectal cancer cells
In assessing human cancer cell lines for the concordance of Axl mRNA and Axl protein levels with Sp1/Sp3 expression (Figures 7a and 7b) , Rko, HCT116, SW480 (colorectal cancer) and HeLa (derived from cervical cancer) cell lines showed high endogenous expression of Axl, which was paralleled by high Sp1 and Sp3 mRNA and protein levels. However, another group of colorectal cancer cell lines (HCT15, HT29, Geo, WiDr and Colo206f) showed almost undetectable basal Axl gene expression despite moderate expression levels of Sp1 and Sp3 mRNA and protein. This observation prompted us to speculate that, apart from Sp1 and Sp3, other potentially epigenetic mechanisms could be influencing basal Axl gene expression.
In order to investigate one potential epigenetic mechanism with regards to the methylation of CpG sites, the colorectal cell lines Colo206f and WiDr, characterized by low constitutive Axl expression, were treated with increasing concentrations of a selective inhibitor of DNA methyltransferases (5-aza-dC). In 5-aza-dC-treated cells, Axl and Sp3 expression was significantly induced in a dose-dependent manner, whereas no significant differences were observed in Sp1 mRNA expression (Figure 8a) . To identify methylated regions of the Axl promoter and to compare potential methylation between high-and low-Axl expressing colorectal cancer cells, 1 μg of genomic DNA from WiDr (lowAxl expressing) and Rko (high-Axl expressing) cells was subjected to bisulfite conversion. DNA sequencing revealed that Sp a, Sp b and Sp c were partially methylated in low-Axl-expressing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
DISCUSSION
Axl is a member of the mammalian Tyro 3 RTKs, which are widely overexpressed in different cancers [18] , and an increasing number of reports have shown an essential functional relevance of Axl in tumour progression, invasion, metastasis, antiapoptosis, angiogenesis and immunological escape [12, [22] [23] [24] [25] .
In the present study, we have systematically characterized the promoter of this highly important gene in diverse colorectal cell lines and also in the HeLa cell line for the first time. In the present paper, we have focused on delineating the minimally required basal Axl promoter to drive endogenous gene expression. In this context, we have clearly identified five different Sp-binding regions within the minimally required basal promoter region −556 to −183, in which Sp1 and Sp3 transcription factors bound to. The dominant role of Sp1 and Sp3 in controlling Axl gene expression was solidified by either overexpression or siRNA knockdown of Sp1 and Sp3, which led to decreased or increased promoter activity and Axl protein levels respectively. This is supported by mithramycin treatment, which showed a decrease in promoter activity, mRNA and protein levels, and also in Sp1 and Sp3 expression, brought about by this GC-rich region binding molecule. In addition to Sp1 and Sp3 acting as essential regulators of basal Axl gene expression, we show evidence that the methylation of CpG sites within specific Sp1 motifs, and also in promoter regions flanking these motifs, modulates Axl gene expression.
Sp1 and Sp3 are zinc-finger proteins that belong to the Sp family of transcriptional factors, regulating the transcription of many housekeeping genes, but also tissue-specific, viral and inducible genes, by binding and acting through the GC-box motif GG-GCGG [26, 27] . Sp-family members are characterized by a motif of three conserved C 2 H 2 zinc fingers, which form the DNAbinding domain [27] . Among Sp-family transcription factors, very little functional activities are known for Sp2 and Sp4. Sp2 is characterized by the glutamine-rich activation domain, indicating that it can act as a potential activator [21] , whereas Sp4 is a tissue-specific Sp-family member predominately found in the brain. In the present study, we observed binding of Sp2, in addition to Sp1 and Sp3, to some of the five Sp-binding motifs identified within the Axl promoter, and so it is certainly possible that, besides Sp1 and Sp3, Sp2 will also transactivate the Axl promoter via these sites. However, due to the limited availability of suitable constructs and antibodies, our study focused on Sp1 and Sp3, Sp1 being characterized by glutamine-rich regions which act as strong activation domains [28] , and a short C-terminal domain D, which is required for synergistic activation [29] . Sp3 has been shown to be able to act as either a transcriptional activator [30, 31] or transcriptional repressor [32] by binding to GC-rich regions. It has been suggested that the functional activation of Sp3 also depends on the presence of binding sites within target promoters, since it has been observed that promoters with a single binding site were strongly activated, whereas promoters with multiple binding sites were either inactive or weakly activated by Sp3 [33] . Sp1 and Sp3 share more than 90% sequence similarity in the DNA-binding domain and bind to the same GCrich elements. Therefore it has been hypothesized that the ratio between Sp1 and Sp3 or the cellular background may lead to either activation or repression of gene expression [34, 35] . For the cell lines investigated in our present paper, we did not find a significant correlation between the ratio of expression of Sp1 and Sp3 with the level of endogenous Axl mRNA or Axl protein (results not shown), therefore it is unlikely that a similar situation is relevant for the expression of Axl.
Within the −556 to −181 region minimally required for Axl promoter activity, we identified five Sp consensus-binding sites within a generally GC-rich region. With EMSA and ChIP studies, we clearly showed that Sp1 and Sp3 bound strongly to oligonucleotides corresponding to all of the Sp-binding motifs, and also to the endogenous GC-rich region. Functional mutagenesis studies targeting these Sp-binding sites revealed that the Sp a and Sp b motifs are especially indispensable for basal Axl promoter activity, whereas the Sp c, Sp d and Sp e sites show an additional modulating relevance for basal promoter activity. However, since a construct mutated for all five Sp-binding sites still exerted a minimal reporter activity compared with an empty vector control, we cannot rule out the possibility that additional parameters besides Sp factors binding to the five identified Sp sites might remotely co-regulate the Axl promoter. For example, Sp family members might bind to GC-rich regions other than the Sp-consensus motifs identified within the Axl core promoter. Moreover, other zinc-finger proteins with a high affinity towards GC-rich regions, such as BTEB1 (basis-transcription-element-binding protein 1), TIEG1 (transforming growth factor β-inducible early protein 1) or TIEG2 [36] [37] [38] , might bind to the GC-rich Axl core promoter. In addition, an AP-1 and an MZF1 motif also identified within the core promoter might contribute to minimal activation; however, this is unlikely, since mutations of either of the motifs did not change reporter activity in our luciferase experiments (results not shown). Still, our co-transfection experiments of Sp1 or Sp3 with the Axl promoter showed a significant increase in promoter activity in the SL2 cell line (which does not endogenously express human Sp1 and Sp3) [39, 40] , and our observation that Sp1 or Sp3 significantly increase Axl gene expression (whereas siRNA knockdown of either Sp1 or Sp3 dramatically reduced Axl promoter activity and expression) clearly imply that both transcription factors are essential for Axl promoter transactivation and endogenous gene expression [40] . In this context, it is of note that a second ligand of the Axl receptor, protein S, has also been shown to be constitutively regulated by Sp1 and Sp3 transcription factors [39] . Although these experiments have been conducted mainly in the hepatocytic cell line HepG2, it is interesting to speculate that, in gastrointestinal tumours, Sp1 and Sp3 may regulate the constitutive expression of a RTK which is highly relevant for tumour progression, invasion and angiogenesis, in addition to up-regulating one of its specific ligands, to enhance tumour progression.
Mithramycin, having been shown to reduce the activity of the Sp1 promoter as well as inhibiting Sp1 binding [41] , in our present study also reduced Axl promoter activity in a dosedependent manner and almost abolished the expression of Axl, Sp1 and Sp3 mRNA and protein within 24 h [40] . Mithramycin is a cell-permeable reagent frequently used to explore the sequence dependence of DNA-binding factors known to bind to GC-rich regions by steric hindrance. In our present study, overexpression or knockdown of Sp1 or Sp3 had a significant, but not 100%, impact on Axl promoter activity, whereas mithramycin treatment completely abolished the expression of Axl mRNA or Axl protein. One explanation for this small discrepancy might be that all GC-rich regions of the Axl promoter were completely blocked by mithramycin. Moreover, as already stated above, other transcription factors known to bind to GC-rich regions and/or exhibit similar binding specificity as Sp1, such as BTEB1, TIEG1 or TIEG2, might add to Axl promoter transactivation to a small extent and might have also been blocked by mithramycin. At present, we cannot rule out the possibility of a remote additional impact of other such transcription factors apart from Sp1 or Sp3 in in vivo conditions. In the present paper, we also provide the first systematic screening of a number of human colorectal cancer cell lines in addition to HeLa cells (a cervical cancer cell line) for mRNA transcript and protein levels of human Axl, Sp1 and Sp3. In Rko, HCT116, SW480 and HeLa cells, a high endogenous Axl expression correlated with high amounts of endogenous Sp1 and Sp3. On the other hand, HCT15, HT29, Geo, WiDr and Colo206f cells did not show significant endogenous Axl gene expression, although they have detectable transcript and protein levels of Sp1 or Sp3. This certainly can be explained by the fact that Sp1 and Sp3 regulate many more genes that might also be of relevance for the latter cell lines, besides Axl. Moreover, the activity of Sp family transcription factors towards specific promoter motifs is certainly not only defined by their expression, but also by post-translational modifications and protein-protein interactions. It has been well described that post-translational modifications, such as phosphorylation, glycosylation or sumoylation, modify the transactivating activity of, for example, Sp1 [42, 43] . Also, Sp1 can exert indirect effects on transcription via its interaction with, for example, the chromatin remodelling factors p300 or PCAF [p300/CREB (cAMP-response-element-binding protein)-binding protein-associated factor] and other DNA-binding proteins [26, 42, 44, 45] . Furthermore, as stated previously, the ratio of Sp1 to Sp3 in certain cellular contexts may determine the degree of activation [46, 47] . Such mechanisms can certainly explain the discrepancy between Axl, Sp1 and Sp3 expression levels found in some of the cell lines investigated.
Our finding that methylation of some of the Sp-binding sites and their flanking regions within the basal Axl promoter may modulate Axl gene expression certainly merits discussion. CpG methylation is well known to be important for gene imprinting [48] , cell-cycle control, tumour suppression, embryonic development, differentiation and other phenomena [49] . Specifically, there have been many interesting reports showing that the methylation of CpG sites within Sp-transcription-factor-binding motifs, but also of their flanking regions, might affect the binding and transactivating potential of Sp1 and Sp3 [50] [51] [52] . In the present study, we found that the basal Axl promoter is extremely GCrich, with 19 CpG sites within the region −669 to −97 and harbours many putative CpG methylation sites. CpG methylation can inhibit Sp1 binding by two mechanisms, either by directly inhibiting the binding of Sp1, or by contributing to competition with other factors, such as MeCP2 (methyl CpG-binding protein), for binding sites [53, 54] . In our present study, we found that some of the CpG sites within Sp-family-binding motifs, or within adjacent CG-rich regions, were partially methylated in WiDr cells, which are characterized by an almost undetectable endogenous Axl gene expression. In contrast, in high-Axl-expressing Rko cells, no methylation of such sites was found. This observation suggests that CpG methylation of the basal Axl promoter is related to endogenous Axl gene expression. To substantiate this hypothesis, we found that a demethylating agent (5-aza-dC) was able to activate Axl gene expression in the low-Axl-expressing WiDr cell line. Moreover, not only Axl, but Sp3 expression was also induced by 5-aza-dC in Colo206f and WiDr cells in a dosedependent manner. This supports the hypothesis that in low-Axl expressing-colon cancer cells, transcription of the Axl gene is kept silent by partial methylation of CpG islands within the basal promoter. The additional interesting observation that 5-aza-dC directly affected the expression of Axl and Sp3, but not Sp1, prompts us to speculate that the demethylating agent interferes with the ability of Sp1 and Sp3 to transactivate Axl gene expression in two different ways: in the case of Sp3, it may directly interfere with Sp3 gene expression by demethylating sequences within its gene promoter. In contrast, it may directly modulate Sp1 binding to the Axl gene promoter by demethylating target sites within the Axl promoter sequence. Thus the effect of 5-azadC on Sp1/Sp3-regulated Axl promoter activity might be both direct and indirect.
Taken together, this is the first study to characterize the Axl gene promoter and to establish a major role for Sp1, Sp3 and also methylation of the core promoter as key regulators of constitutive Axl gene expression in diverse colorectal and HeLa cancer cells. Further ongoing studies will elucidate the function of further upstream transcriptional elements in the constitutive and inducible expression of this RTK, which is essential for many functions associated with cancer.
